These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1924930)

  • 21. Recommended standard theophylline doses are inadequate in chronic obstructive pulmonary disease.
    Savage J; Wiseman IC
    S Afr Med J; 1987 Apr; 71(8):508-9. PubMed ID: 3563816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The combined effect of theophylline and terbutaline in patients with chronic obstructive airway diseases.
    Lamont H; van der Straeten M; Pauwels R; Moerman E; Bogaert M
    Eur J Respir Dis; 1982 Jan; 63(1):13-22. PubMed ID: 7040097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Theophylline treatment of irreversible, chronic obstructive pulmonary disease].
    Iversen ET; Eiken PA; Nielsen LM; Laursen LC; Maltbaek N; Tønnesen FV; Rasmussen FV
    Ugeskr Laeger; 1994 Sep; 156(39):5696-9. PubMed ID: 7985256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of theophylline on cortisol plasma concentrations in patients with chronic obstructive pulmonary disease.
    Gimeno F; Steenhuis EJ; Jonkman JH
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):139-43. PubMed ID: 2187001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical significance of the pharmacokinetic determination of theophylline].
    Gao L
    Zhonghua Yi Xue Za Zhi; 1986 Mar; 66(3):137-40, 188. PubMed ID: 3094865
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical functional study of a new delayed-action preparation of "once a day" anhydrous theophylline in patients with chronic obstructive bronchopneumopathy].
    Gatto PG; Bruzzoni A; Valenti V
    Clin Ter; 1989 Jul; 130(1):45-9. PubMed ID: 2529079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Microcrystallinic theophylline, plasma concentration and adverse effects in patients with obstructive lung disease].
    Talseth T; Kongerud J; Boye NP; Bredesen JE
    Tidsskr Nor Laegeforen; 1981 Oct; 101(29):1648-50. PubMed ID: 7339948
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hemodynamics of pulmonary circulation in patients with chronic obstructive lung disease and pulmonary hypertension as dependent on the theophylline concentration of the serum].
    Grützmacher I; Schicht R; Schlaeger R; Sill V
    Prax Klin Pneumol; 1984 Jan; 38(1):19-25. PubMed ID: 6709589
    [No Abstract]   [Full Text] [Related]  

  • 29. Rifampicin-isoniazid and delayed elimination of theophylline: a case report.
    Dal Negro R; Turco P; Trevisan F; De Conti F
    Int J Clin Pharmacol Res; 1988; 8(4):275-7. PubMed ID: 3182118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical study of theophyllinemia in patients with obstructive bronchial syndrome].
    Vasiliev CB; Burnea D; Vasiliev R; Popescu C; Anastasatu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(2):169-80. PubMed ID: 6316471
    [No Abstract]   [Full Text] [Related]  

  • 31. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Theophylline pharmacokinetics in patients with mild or severe airway obstruction.
    Rizzo A; Mirabella A; Ferrara G; Pipitone P; Bellia V; Bonsignore G
    Bull Eur Physiopathol Respir; 1982; 18(6):811-8. PubMed ID: 6927536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dose titration with Euphylong following prior determination of serum concentration in the steady state].
    Schnabel D; von Treufels S; Oellerich M; Böttger HC; Sybrecht GW
    Pneumologie; 1990 Feb; 44 Suppl 1():287-8. PubMed ID: 2367392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-mortem concentrations of salbutamol, terbutaline and theophylline in asthma patients.
    Lindsjö M; Boman G; Lindström B; Strandberg K; Wiholm BE
    Eur J Respir Dis; 1987 Jul; 71(1):2-9. PubMed ID: 3653302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The pharmacokinetic characteristics of theophylline in patients with chronic nonspecific intestinal diseases in relation to its routes of administration into the gastrointestinal tract].
    Kukes VG; Fazylov AV; Kirkin BV; Kurapov AP; Blinov IL
    Ter Arkh; 1993; 65(2):52-4. PubMed ID: 9133013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum theophylline and ventilatory function in chronic obstructive lung disease. Comparison between two slow-release formulations of theophylline.
    Tantucci C; Grassi V; Verdecchia P; Cornelli U; Sorbini CA
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):560-4. PubMed ID: 3905630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Audit of serum theophylline concentrations in patients from general practice.
    Howard JC
    J R Coll Gen Pract; 1987 Mar; 37(296):105-6. PubMed ID: 3681843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical results obtained from a new controlled release theophylline preparation.
    Nolte D
    Br J Clin Pract Suppl; 1984; 32():14-7. PubMed ID: 6432017
    [No Abstract]   [Full Text] [Related]  

  • 39. Individualization of theophylline dosage: a Bayesian method evaluated in patients with once-daily dosing.
    Martz W; Oellerich M; Schnabel D; Sybrecht GW
    Ther Drug Monit; 1991 Sep; 13(5):420-4. PubMed ID: 1957334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug monitoring: theophylline--comparison of 3 methods for determination].
    Kropp R; Göbel D
    Pneumologie; 1995 Feb; 49(2):60-4. PubMed ID: 7724504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.